Work

The mechanisms and treatment of weight loss in cancer

Year: 1992
Type: review
Abstract: It is always a very great pleasure when one meets an individual whose work has been of considerable scientific importance.I was honoured to have met Sir David Cuthbertson on several occasions towards the end of his life and, thus, it gives me particular pleasure to be invited by the Clinical Metabolism and Nutritional Support Group of the Nutrition Society to give this lecture in his memory.Sir David was particularly interested by the metabolic response to trauma and in this lecture I wish to dwell on another part of the spectrum of the response to injury in terms of the metabolic disturbance in patients with cancer.It goes without saying that the majority of patients with cancer will eventually lose weight and a proportion become emaciated to the extent that they appear to die of starvation.This syndrome is known as cancer cachexia, the term cachexia being derived from the Greek words 'kaxos' and 'hexis' meaning poor condition.The patient with cachexia is characterized by a group of symptoms including anorexia, early satiety, marked weight loss, aesthenia, anaemia and oedema.The importance of weight loss in cancer has long been recognized.As far back as 1932 Warren in a post-mortem study estimated that as many as 22% of patients with cancer die primarily as a result of cachexia (Warren, 1932).More modern studies would put this percentage at perhaps 10 (Inagaki et al. 1974).Nevertheless, currently the majority of cancer patients die from sepsis, and there remains the complex inter-relationship between poor nutritional status and a propensity to infection.Unfortunately, for the majority of patients whose cancer has spread beyond the organ of origin, neither surgery, radiotherapy or chemotherapy is able to offer a cure.With the recognition of the morbidity and mortality associated with cachexia, the past 15 years have seen attempts to use nutritional support to try to reverse the nutritional deficit associated with progressive cancer growth.These studies have, however, not met with great success.Conventional nutritional support does not readily reverse the nutritional deficits associated with progressive tumour growth (Nixon et al. 1981; Cohn et al. 1982) and not surprisingly nutritional support has failed to reduce overall morbidity and mortality (Brennan, 1981;Chlebowski, 1986).These disappointing results have led investigators back to the drawing board to try to understand the fundamental reasons for
Language: English
Field: Medicine
Open Access status: bronze
OpenAlex ID: W2020184553
FWCI: 0.147
Cites: 58
Cited by: 169
Related to: 10